Adaptin Bio, Inc. APTN
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.40M | -5.71M | -5.17M | -4.66M | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 53.70K | 162.10K | -- |
| Total Other Non-Cash Items | 1.29M | 1.09M | 426.80K | 453.00K | -- |
| Change in Net Operating Assets | 1.59M | 1.52M | -90.90K | 78.90K | -- |
| Cash from Operations | -2.52M | -3.09M | -4.78M | -3.96M | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | -- |
| Total Debt Repaid | -170.90K | -92.40K | -275.00K | -275.00K | -- |
| Issuance of Common Stock | 2.58M | 1.65M | 7.16M | 6.16M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -569.50K | -538.20K | -1.68M | -1.46M | -- |
| Cash from Financing | 1.84M | 1.02M | 5.20M | 4.43M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -681.00K | -2.07M | 425.10K | 463.80K | -- |